Pelthos Therapeutics Inc. Cash
Pelthos Therapeutics Inc. (PTHS) had Cash of $14.20 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2025-11-13
- 2025-09-30: Cash $14.20M.
- 2025-06-30: Cash $59.17K.
- 2025-03-31: Cash $131.32K.
- 2024-12-31: Cash $513.00K; Cash as first filed $513.44K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2025-09-30 | $14.20M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $59.17K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $131.32K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $513.00K 10-Q · filed 2025-11-13 | $513.44K 10-K · filed 2025-03-27 |
| 2024-09-30 | $1.25M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.41M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.77M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $96.39K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $55.07K 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |